The Pancreatic Cancer Action Network is pleased to announce Steven Leach, MD, Memorial Sloan-Kettering Cancer Center, New York, NY, as the newly appointed chair of the organization’s prestigious Scientific and Medical Advisory Board. The organization also welcomes four new members to the board: Howard Crawford, PhD, University of Michigan, Ann Arbor, MI; Channing Der, PhD, University of North Carolina, Chapel Hill, NC; Hedy Kindler, MD, University of Chicago, Chicago, IL; and Nipun Merchant, MD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.
“I am thrilled to welcome Drs. Crawford, Der, Kindler and Merchant to our Scientific and Medical Advisory Board, and we congratulate Dr. Leach on his new role as chair,” stated Lynn Matrisian, PhD, MBA, vice president of scientific and medical affairs for the Pancreatic Cancer Action Network. “We look forward to working with each of them in this new capacity and utilizing their broad experience and knowledge as we work towards our goal to double pancreatic cancer survival by 2020.”
The Pancreatic Cancer Action Network’s Scientific and Medical Advisory Board provides scientific and clinical expertise to guide the organization in planning and implementing our research initiatives and our information and education services for patients, their families and caregivers, and healthcare professionals. It is composed of leading cancer scientists, clinicians and healthcare professionals from institutions across the United States who specialize in pancreatic cancer.
Learn more about our SMAB in our press release.